tiprankstipranks
Cresco Labs (CRLBF)
OTHER OTC:CRLBF

Cresco Labs Stock Price & Analysis

1,824 Followers

CRLBF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.39 - $10.42
Previous Close$3.3
Volume2.14M
Average Volume (3M)426.11K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$57.69M
Total Debt (Recent Filing)$176.56M
P/E Ratio-2.8
Beta2.01
Next EarningsNov 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.19
Shares Outstanding207,731,000
R-Squared0.06
Standard Deviation30.49
10 Day Avg. Volume494,599
30 Day Avg. Volume426,105
P/B Ratio-10.28
P/S Ratio0.52
P/CF Ratio22.00
P/FCF Ratio-8.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside106.03% Upside
Rating ConsensusModerate Buy
Alpha5.68
Number of Analyst Covering7


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

CRLBF FAQ

What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was $2.39 and its highest was $10.42 in the past 12 months.
    What is Cresco Labs’s market cap?
    Currently, no data Available
    When is Cresco Labs’s upcoming earnings report date?
    Cresco Labs’s upcoming earnings report date is Nov 10, 2022 which is in 34 days.
      How were Cresco Labs’s earnings last quarter?
      Cresco Labs released its earnings results on Aug 17, 2022. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of -$0.005 by -$0.015.
        Is Cresco Labs overvalued?
        According to Wall Street analysts Cresco Labs’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Cresco Labs pay dividends?
          Cresco Labs does not currently pay dividends.
          What is Cresco Labs’s EPS estimate?
          Cresco Labs’s EPS estimate is -$0.01.
            How many shares outstanding does Cresco Labs have?
            Cresco Labs has 278,829,680 shares outstanding.
              What happened to Cresco Labs’s price movement after its last earnings report?
              Cresco Labs reported an EPS of -$0.02 in its last earnings report, missing expectations of -$0.005. Following the earnings report the stock price went down -3.2%.
                Which hedge fund is a major shareholder of Cresco Labs?
                Currently, no hedge funds are holding shares in CRLBF

                ---

                Cresco Labs Stock Analysis

                Smart ScoreNeutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                6
                The Cresco Labs stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Cresco Labs

                Cresco Labs Inc is a Canada based company engaged in the production and sale of cannabis. The company distribute its products to dispensaries nationwide, including several dispensaries owned and operated by its team. Its product includes Reserve, Remedi, Mindy's. All the revenues of the company were generated in the United States. It has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, and Arizona.

                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Johnson & Johnson
                Eli Lilly & Co
                Pfizer
                Merck & Company
                Bristol Myers

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis